EP2310493A1 - METHOD FOR CONTROLLING pH, OSMOLALITY AND DISSOLVED CARBON DIOXIDE LEVELS IN A MAMMALIAN CELL CULTURE PROCESS TO ENHANCE CELL VIABILITY AND BIOLOGIC PRODUCT YIELD - Google Patents
METHOD FOR CONTROLLING pH, OSMOLALITY AND DISSOLVED CARBON DIOXIDE LEVELS IN A MAMMALIAN CELL CULTURE PROCESS TO ENHANCE CELL VIABILITY AND BIOLOGIC PRODUCT YIELDInfo
- Publication number
- EP2310493A1 EP2310493A1 EP09791207A EP09791207A EP2310493A1 EP 2310493 A1 EP2310493 A1 EP 2310493A1 EP 09791207 A EP09791207 A EP 09791207A EP 09791207 A EP09791207 A EP 09791207A EP 2310493 A1 EP2310493 A1 EP 2310493A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- carbon dioxide
- cell culture
- dissolved carbon
- osmolality
- dissolved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 title claims abstract description 463
- 229910002092 carbon dioxide Inorganic materials 0.000 title claims abstract description 242
- 239000001569 carbon dioxide Substances 0.000 title claims abstract description 241
- 238000004113 cell culture Methods 0.000 title claims abstract description 124
- 210000004962 mammalian cell Anatomy 0.000 title claims abstract description 107
- 238000000034 method Methods 0.000 title claims abstract description 75
- 230000003833 cell viability Effects 0.000 title claims abstract description 26
- 230000010261 cell growth Effects 0.000 claims abstract description 12
- 210000004027 cell Anatomy 0.000 claims description 86
- 238000004519 manufacturing process Methods 0.000 claims description 45
- 239000006143 cell culture medium Substances 0.000 claims description 35
- 230000003698 anagen phase Effects 0.000 claims description 31
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 230000006378 damage Effects 0.000 abstract description 10
- 230000000670 limiting effect Effects 0.000 abstract description 3
- 238000011217 control strategy Methods 0.000 abstract 1
- 239000007789 gas Substances 0.000 description 103
- 239000007788 liquid Substances 0.000 description 50
- 239000012071 phase Substances 0.000 description 48
- 239000000243 solution Substances 0.000 description 47
- 230000008569 process Effects 0.000 description 44
- 239000000047 product Substances 0.000 description 41
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 37
- 239000001301 oxygen Substances 0.000 description 37
- 229910052760 oxygen Inorganic materials 0.000 description 37
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 30
- 239000002609 medium Substances 0.000 description 23
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 22
- 239000000203 mixture Substances 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 238000007792 addition Methods 0.000 description 21
- 230000001965 increasing effect Effects 0.000 description 21
- 239000000523 sample Substances 0.000 description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 17
- 235000015097 nutrients Nutrition 0.000 description 17
- 239000003570 air Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 11
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 11
- 238000010408 sweeping Methods 0.000 description 11
- 239000002585 base Substances 0.000 description 10
- 238000005086 pumping Methods 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 238000003306 harvesting Methods 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 238000005457 optimization Methods 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 238000013019 agitation Methods 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000002706 hydrostatic effect Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- 239000007995 HEPES buffer Substances 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 238000010923 batch production Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 230000003139 buffering effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000003134 recirculating effect Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 238000004886 process control Methods 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 238000013341 scale-up Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000006173 Good's buffer Substances 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002631 hypothermal effect Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000006193 liquid solution Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000011956 best available technology Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 238000011148 full scale manufacturing process Methods 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- -1 hydrogen ions Chemical class 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000010254 physiological adaptation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029219 regulation of pH Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000010891 toxic waste Substances 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
Definitions
- the present invention relates to mammalian cell culture processes, and more particularly to methods for enhancing cell growth, cell density, cell viability, product concentration and product yield through improved control of process parameters including pH, osmolality and dissolved carbon dioxide level of the cell culture medium.
- Bioreactors adapted for culturing suspensions of genetically optimized mammalian, insect or other cell types.
- Mammalian cell culture bioreactors typically have several hundred to several thousand liters in working volume.
- Most common full scale manufacturing plants have bioreactors with working volumes ranging from approximately 1,000 liters up to 25,000 liters.
- Drug candidates for clinical trials are produced in laboratory scale bioreactors having five (5) liters to several hundred liters of working volume.
- a seed culture inoculum is typically prepared. This involves culturing production cells in a series of flasks in incubators and/or smaller bioreactors of increasing volume until enough cells are available for inoculation into the production bioreactor. The process involves transferring a ceil population from one culture vessel to a larger one. Generally, a 20% dilution of the cell population is used for each transfer or subculture. In the incubator, the flasks with culture medium are clamped to a rotating platform to swirl the culture and facilitate gas transfer between the culture medium and the atmosphere in the incubators.
- the incubator for a mammalian cell culture process is set at 37 0 C with 5% carbon dioxide (CO 2 ) and a humidity level higher than about 80%. Similar temperatures and CO 2 levels are used for seed cultures grown in bioreactors. When the seed culture reaches a sufficient volume and cell density, it is inoculated into the production bioreactor.
- CO 2 carbon dioxide
- pH is typically controlled by adding basic or acidic solutions when necessary during the process.
- Commonly used base solutions include sodium bicarbonate, sodium carbonate and sodium hydroxide solutions.
- Dissolution of carbon dioxide (CO 2 ) is commonly used to achieve a more acidic pH.
- CO 2 carbon dioxide
- the preferred temperature of the culture medium or solution for mammalian cell cultivation processes is about 37 0 C.
- the desired level of dissolved oxygen in the culture medium or solution is typically achieved through air sparging using sparger installed on the bottom of the bioreactor, along with agitation of the culture medium or solution using impellers which breakup the large air/oxygen bubbles to enhance the transfer of oxygen to the cell medium from the sparged air bubbles.
- Purging the bioreactor headspace with a cover gas provides a limited degree of surface gas exchange.
- air-sparging and agitation of the culture medium or solution may result in foaming and shear damage to the mammalian cells which adversely impacts cell viability. Accumulations of foam on the surface of the culture medium also serve to further limit surface gas exchange and to reduce the available working volume of the bioreactor.
- Temperature probes, pH detectors, dissolved oxygen probes and dissolved CO 2 probes or sensors are used to monitor the temperature, pH, dissolved oxygen and dissolved CO 2 levels of the cell medium or solution in real time.
- cell culture medium or solution samples can be withdrawn from the bioreactor at selected intervals to determine cell density and cell viability, as well as to analyze other characteristics such as metabolites and osmolality. Based on such analytical results, additional feed or other additives can be added to the cell culture medium or solution in an effort to prolong the cell viability and increase production of biological products.
- a prescribed lower threshold is often determined empirically based on the results of down-stream recovery and purification of the harvested biological products.
- the mammalian cells exhibit three phases, namely the lag phase, the exponential growth phase, and the stationary or production phase.
- the lag phase occurs immediately after inoculation and is generally a period of physiological adaptation of mammalian cells to the new environment.
- the mammalian cells are considered in the exponential growth phase.
- the exponential growth phase the mammalian cells multiply and cell density increases exponentially with time. Many cells actually start to produce the desired protein, antibody or biological product during some point in the exponential growth phase.
- Cell density refers to the total number of cells in culture, usually indicated in the density of viable and non-viable cells.
- Mammalian cells are known to be sensitive to the amount of dissolved carbon dioxide in the cell culture media or solution. Mammalian cell cultures exposed to excess carbon dioxide levels during the exponential growth phase may demonstrate reduced production of monoclonal antibodies or other desired biological products. Before inoculation, the pH of the slightly alkaline culture media has to be lowered with carbon dioxide adjusted to an optimum value. This often leads to elevated levels of dissolved carbon dioxide at the beginning of the lag phase of many mammalian cell culture processes. [0010] Dissolved carbon dioxide in mammalian cell culture bioreactors originates from chemical and biological sources.
- the chemical source of carbon dioxide is equilibrium chemical reactions occurring within the cell culture medium or solution that includes a selected amount of a buffer solution containing sodium bicarbonate and/or sodium carbonate. Additionally, carbon dioxide may be directly sparged into the slightly alkaline culture medium or solution to reduce the pH of the broth to a prescribed level, usually around 7.0, resulting in more dissolved carbon dioxide.
- the biological source of carbon dioxide is a product of the respiration of the mammalian cells within the bioreactor. This biological source of carbon dioxide increases with cell density and generally reaches its maximum value at about the same time that cell density within the bioreactor is maximized.
- the conventional method of removing or stripping dissolved carbon dioxide from a mammalian cell culture solution is by sparging the cell culture solution with air or a gas mixture of air/oxygen/nitrogen in agitated tanks.
- gas sparging in agitated tanks results in adverse effects to the cell culture process.
- the gas-bubble breakage at the tip of the rotating agitator is a source of high shear rate that damages mammalian cell membranes, often sufficiently to cause cell death. Even when damage is sub-lethal, cell productivity is compromised in the period that the damaged membrane is repaired.
- sparging air or nitrogen into the bioreactor creates gas bubbles rising to the surface of the solution within the bioreactor where the gas is released into the headspace.
- Gas bubble breakage at the top surface of the cell culture solution is often more damaging to the mammalian cells than the damage caused by the agitator. Restraining the agitator speed and limiting the gas sparging rate are currently viewed as the best means to avoid such damage and increase cell viability. However, these measures reduce the amount of carbon dioxide that can be removed and the excess that cannot be removed also inhibits cell growth and viability. These disadvantages are particularly challenging to overcome in large, commercial-scale bioreactors where the shear rate goes up substantially with the diameter of the impellers. Also, the greater hydrostatic head of large scale bioreactors tends to increase the solubility of carbon dioxide, meaning that more needs to be removed to maintain dissolved CO 2 levels within an optimal range.
- the present invention may be characterized as a method for enhancing cell growth, cell viability, cell density, product yield and product concentration in a mammalian cell culture process comprising the steps of: (a) maintaining the dissolved carbon dioxide in a cell culture medium at a generally stable level of less than 10% concentration of dissolved carbon dioxide during a growth phase or production phase of the mammalian cell culture process; and maintaining the osmolality in the cell culture medium at a value of between about 300 mOsmol/kg and 700 mOsmol/kg during the growth phase of the mammalian cell culture process.
- Fig. 1 is a graph that depicts percentage of dissolved carbon dioxide for three different runs of a mammalian cell line in a process having a moderate level of osmolality, wherein the three runs include one having a high peak level of dissolved carbon dioxide, another having moderate peak level of dissolved carbon dioxide, and the third having a low peak level of dissolved carbon dioxide; [0018] Fig.
- FIG. 2A is a graph that depicts viable cell density in a mammalian cell culture process as a function of time in days for the three different runs of a mammalian cell line in the process from Fig. 1 having a moderate osmolality;
- Fig. 2B is a graph that depicts cell viability as a percentage as a function of time in days for the three different runs of a mammalian cell line in the process from Fig. 1 having a moderate osmolality;
- Fig. 2C is a graph that depicts total cell density cell in a mammalian cell culture process as a function of time in days for the three different runs of a mammalian cell line in the process from Fig. 1 having a moderate osmolality
- Fig. 3 is a graph that depicts biologic product concentration in a mammalian cell culture process as a function of time in days for the three different runs of a mammalian cell line in the process from Fig. 1 having a moderate osmolality;
- Fig. 4 is a graph that depicts percentage of dissolved carbon dioxide in a mammalian cell culture process as a function of time in days for two different runs of a mammalian cell line in a process having generally constant or stable osmolalities wherein the first run includes a low peak level of dissolved carbon dioxide and the second run includes a moderate overall peak level of dissolved carbon dioxide;
- Fig. 5 is a graph that depicts viable cell density in a mammalian cell culture process as a function of time in days for the two different runs of a mammalian cell line in the process from Fig. 4 having a moderate osmolality and generally constant or stable levels of dissolved carbon dioxide;
- Fig. 6 is a graph that depicts biologic product titer or concentration in a mammalian cell culture process as a function of time in days for the two different runs of a mammalian cell line in the process from Fig. 4 having a moderate osmolality and generally constant or stable levels of dissolved carbon dioxide;
- Fig. 7 is a graph that depicts the dissolved carbon dioxide profile during the growth and production phases of a mammalian cell culture process
- Fig. 8 is a graph that depicts viable cell density in a mammalian cell culture process as a function of time in days for yet another two different runs of a mammalian cell line in which different but generally constant levels of dissolved carbon dioxide are maintained;
- Fig. 9 is a graph that depicts osmolality in a mammalian cell culture process as a function of time in days for the two different runs of the mammalian cell line in the process from Fig. 8 having different but generally constant levels of dissolved carbon dioxide;
- Fig. 10 is a graph that depicts percentage of viable cells in a mammalian cell culture process as a function of time in days for the two different runs of the mammalian cell line in the process from Fig. 8 having different but generally constant levels of dissolved carbon dioxide;
- Fig. 11 is a graph that depicts biologic product yield or titer in a mammalian cell culture process as a function of time in days for the two different runs of a mammalian cell line in the process from Fig. 8 having different but generally constant levels of dissolved carbon dioxide;
- Fig. 12 is a graph that depicts dissolved carbon dioxide in a mammalian cell culture process as a function of time in days for the two different runs using the present Dynamic Gas Control (DGC) process compared against a standard run;
- DGC Dynamic Gas Control
- Fig. 13 is a graph that depicts cell viability in a mammalian cell culture process as a function of time in days for the two different runs using the present Dynamic Gas Control (DGC) process compared against a standard run;
- DGC Dynamic Gas Control
- Fig. 14 is a graph that depicts viable cell density in a mammalian cell culture process as a function of time in days for the two different runs using the present Dynamic Gas Control (DGC) process compared against a standard run;
- DGC Dynamic Gas Control
- Fig. 15 is a graph that depicts biologic product yield or titer in a mammalian cell culture process as a function of time in days for the two different runs using the present Dynamic Gas Control (DGC) process compared against a standard run;
- DGC Dynamic Gas Control
- Fig. 16 is a chart that depicts the trend of IgG titer versus peaked dCO 2 in the cell culture process with varying levels of osmolality;
- Fig. 17 is a chart that depicts the trend of IgG titer versus maximum osmolality in the DGC type cell culture process with low levels of dissolved carbon dioxide;
- Fig. 18 is a table that provides the data collected during various cell culture process runs at various combinations of osmolality and dissolved carbon dioxide.
- HC(V has a fairly low dissociation constant, producing only low concentrations of hydrogen ions and achieving only a moderate lowering the solution pH.
- the net result of increasing atmospheric carbon dioxide is to depress pH by shifting the series of equilibria shown in (1) above to the right.
- an alkali such as sodium bicarbonate is used to neutralize the effect of elevated carbon dioxide tension:
- the cells cultured in a batch process reach the exponential growth phase, they become maximally metabolically active and each cell produces its maximum carbon dioxide output.
- the cell density is low, most of carbon dioxide can be removed by sparging the broth with air or sweeping the headspace of the bioreactor with a cover gas or air. A few days into the batch cycle, however, the carbon dioxide generation will exceed the normal carbon dioxide removal capacity of a typical bioreactor.
- the excess carbon dioxide generated by the cells will increase the dissolved carbon dioxide level and decrease the solution pH. In order to maintain the preferred pH, additional base has to be added, resulting in excessive dissolved carbon dioxide and undesirably high osmolality in the bioreactor broth.
- the pH set-point in a mammalian cell culture process can significantly affect the cell-culture performance.
- Cell culture medium pH is known to affect intracellular enzymatic activity of many mammalian cell types. Lowering pH reduces specific glucose consumption and lactate production rates, reducing the risk of glucose depletion or toxic levels of lactate.
- the lower pH set point in typical mammalian cell cultures is about 7.0; a pH below about 6.8 is known to inhibit cell growth.
- Medium or moderate pH values also are known to affect the specific growth rate and specific production rate of mammalian cells, which ultimately affects the overall culture productivity. Excessively low or high pH can kill the cells.
- a pH range of about 7.0 to 7.4 is commonly used in mammalian cell culture processes.
- the wide fluctuations in pH that often occur during the process as, for example, when medium is replenished have an adverse effect on the cells.
- Controlling pH in mammalian cell culture processes is particularly important nowadays because high cell densities (>lxl ⁇ 6 cells/ml) are routinely achieved. Without proper pH control, the cell culture broth can rapidly become acidic when cells are so concentrated.
- human fibroblasts are grown at a higher pH (7.6-7.8) than established cells (pH 7.0-7.4), and it is usual to culture primary cells at a pH of 1.2-1 A.
- the optimum pH for growth of human foreskin fibroblasts (e.g. FS-4) at low culture densities is more alkaline than the optimum pH for growth of human lung fibroblasts (e.g. MRC-5).
- the pH should be about 7.7 to 7.8 for FS-4 cells and about 7.5 to 7.6 for MRC-5 cells.
- equation (1) Since only the dissolved carbon dioxide molecule is transported across the gas- liquid interface, the bicarbonate must be re-associated to form carbon dioxide molecules. Separating equation (1) above into its two sections, it is noted that the reverse reaction set forth below as equations (3) and (4) is generally fast, whereas the first part of the reaction, represented by equation (5), is much slower.
- Control of p ⁇ is a key operating condition as many types of mammalian cells die when the p ⁇ is substantially outside the range between p ⁇ 7.0 and pH7.4.
- the primary target is pH regulation, with dissolved carbon dioxide/bicarbonate levels and osmolality largely uncontrolled and varying significantly during the culture cycle. Few data are available demonstrating the benefits of simultaneously maintaining constant pH, dissolved carbon dioxide and osmolality.
- Culture media must be buffered under two sets of cell growth conditions: (1) in small open containers (e.g., inside an incubator), wherein the carbon dioxide can be lost to the atmosphere, causing the pH to rise, and (2) in a bioreactor when maximal production of carbon dioxide and lactic acid by high cell concentrations causes pH to fall.
- a buffer may be incorporated into the medium to stabilize the pH, but additional gaseous carbon dioxide is still required by some cell lines, particularly at low cell concentrations, to prevent the total loss of dissolved carbon dioxide and bicarbonate from the medium.
- bicarbonate buffer is still used more frequently than any other buffer because of its low toxicity, low cost, and nutritional benefits to the culture.
- Leibovitz L- 15 cell culture medium that does not utilize carbon dioxide for buffering or to control pH.
- Leibovitz L- 15 cell culture medium is preferably used when low tensions of carbon dioxide are required.
- Leibovitz L- 15 contains a higher concentration of sodium pyruvate (550 mg/L) but lacks NaHC(V and does not require carbon dioxide in the gas phase.
- the inclusion of pyruvate in the medium enables mammalian cells to increase their production of carbon dioxide, making them independent of external supplied carbon dioxide, as well as HC(V. Buffering in the Leibovitz L- 15 cell culture medium is achieved via the relatively high amino acid concentrations.
- Increased medium osmolality has been shown to decrease specific cell-growth rate and increase specific production rate.
- the initial medium osmolality can be predicted from the medium formulation.
- the amount of interaction between medium components typically does not make the osmolality significantly different from the sum of each component's contribution.
- Individual osmolalities for components of a typical medium are shown in the following table.
- the growth and function of cells in culture depends on maintaining an appropriate osmolality in the medium. Some cells (e.g. HeLa and other established cell lines) can tolerate wide fluctuations in osmolality. In contrast, primary cells and normal diploid strains are very sensitive to changes in osmolality, and high yields can only be obtained if it is kept within a narrow range. [0064] Controlling osmolality is reported to give more reproducible cultures.
- Osmolality of cell culture media produced by commercial suppliers may differ, probably because of differences in interpretation of original formulations.
- high-yield cultures often require various additions to the medium during the culture cycle. These can include buffers (HEPES), acid (HCl), base (NaOH), growth hormone and nutrients.
- HEPES buffers
- HCl acid
- NaOH base
- growth hormone growth hormone
- NaCl NaCl
- M osm measured osmolality (mOsm).
- X ml of stock of NaCl (mOsm) to be added per milliliter of medium.
- NaCl (1 mg/ml) that must be added to achieve the desired osmolality is calculated.
- Measuring osmolality by freezing point depression is the most practical method, since it does not require diluting the nutrients in the medium or adding large volumes of buffers or saline solutions.
- Vapor pressure depression is another popular method of measuring osmolality.
- the system and method disclosed herein for controlling pH in a mammalian cell culture process comprises ascertaining the desired pH range and desired level of dissolved carbon dioxide for the selected cell culture medium; providing an initial minimum amount of bicarbonate to adjust the pH of the cell culture medium to fall within the desired pH range and produce the desired level of dissolved carbon dioxide within the cell culture media. It was found that this initial equilibrium between dissolved carbon dioxide level and bicarbonate level has a significant impact on final cell viability and product level and yield.
- Enough sodium bicarbonate is added into the medium before inoculation sufficient to allow an equilibrium of dissolved carbon dioxide to attain only a low level, less than 10% and more preferably about 5%.
- pH is maintained by adding sodium hydroxide as required to maintain pH within the desired range to avoid further increase in bicarbonate and an associated increase in dissolved carbon dioxide.
- the sodium hydroxide - a strong base - also maintains pH within the desired range without significantly increasing the osmolality and maintains the levels of dissolved carbon dioxide relatively stably at or near the desired levels. Controlling Dissolved Carbon Dioxide Levels to Enhance Cell Culture Process
- the present system and method provides for tight control of the dissolved carbon dioxide level in the cell culture media both at start-up and during the exponential growth phase which provides a beneficial effect on cell viability during the production phase.
- the accumulated product yield is also influenced by the exposure of the cells to prescribed levels of dissolved carbon dioxide during the growth phase.
- various test runs or test batches demonstrate that tightly controlling the level of dissolved carbon dioxide during the exponential growth phase yields higher accumulated product yield during production phase and also results in a slower degradation or reduction in cell viability during the production phase.
- the present method of controlling the dissolved CO 2 removal employs a bioreactor system having an upward flow impeller disposed within a draft tube disposed in the bioreactor vessel.
- the upward pumping impeller is driven via shaft by a motor outside the bioreactor vessel.
- the upward flow of the impeller provides a top surface renewal method that enhances surface gas exchange in a highly controllable manner.
- the upward pumping impeller moves cell culture medium and suspended mammalian cells from the bottom of the bioreactor vessel toward the liquid/headspace gas interface in the upper part of the reactor. In doing so, dissolved carbon dioxide in the cell culture solution or medium is continuously and rapidly brought to the surface of the liquid in the bioreactor where gas-liquid exchange is occurring.
- a high turnover in the surface liquid allows rapid removal of dissolved carbon dioxide to the headspace.
- the upward flow impeller allows a higher pumping velocity without creating sufficient shear to damage or kill the mammalian cells.
- a sweeping gas consisting of oxygen, nitrogen, air, carbon dioxide or other suitable gases and mixtures thereof that is introduced to the headspace in the bioreactor vessel, where it interacts with the top surface of the solution to achieve the desired liquid gas exchange, and is subsequently exhausted from the headspace in the bioreactor vessel.
- the preferred bioreactor system also may include a plurality of sensors and analyzers including a pH sensor, a dCO 2 sensor, a temperature indicator, a dissolved oxygen analyzer, and a vent gas analyzer. Such sensors and analyzers are coupled as inputs to a system controller (not shown) that controls or adjusts the gas supply of oxygen, nitrogen, and carbon dioxide to the bioreactor vessel.
- the system may also include an exhaust subsystem, a plurality of biological filters as well as a means for sterilizing the bioreactor vessel with water and steam, as needed. .
- the upward pumping impeller is preferably located near the middle of the main bioreactor vessel so that the impeller is submerged for low liquid medium or solution starting levels.
- the impeller speed is adjustable and may be varied throughout the cell culture process to maintain the desired level of dissolved carbon dioxide at all times for the particular mammalian cell culture process.
- the impeller speed is maintained at very low speeds when the liquid or solution level within the bioreactor vessel is low and should be increased as the liquid or solution level rises.
- a draft tube is to be added to increase the upward flowing velocity, resulting in a higher gas exchange rate.
- the impeller speed is preferably highest during the end of the exponential growth phase of the cell culture process, when the liquid or solution level in the bioreactor vessel is also highest.
- the liquid or solution in the bottom of a large bioreactor vessel is exposed to significant hydrostatic pressures, and the dissolved carbon dioxide trapped inside the mammalian cells will be slow to equilibrate.
- the presently disclosed upward pumping impeller mitigates this problem.
- the mammalian cells are exposed to a lower overall average hydrostatic pressure regime and thus achieve a better equilibrium level of dissolved carbon dioxide.
- the continuous axial or upward recirculating of the cell culture medium or solution provides a varying level hydrostatic pressure on the mammalian cells which is believed to enhance the ability of the cells to expel excess dissolved carbon dioxide deep inside the plasma of the cells
- the upward flowing liquid can reach the top surface very rapidly before rolling outward towards the bioreactor wall. This provides a very rapid renewal of the liquid surface which promotes rapid removal of dissolved carbon dioxide.
- impellers can be used to provide the upward recirculating flow with or without the draft tube.
- the upward pumping impeller is a screw impeller or propeller.
- propellers may also be used so long as the lateral or radial flow from the propeller is minimized which, in turn reduces shearing and other damage to the mammalian cells.
- Rapid gas-liquid surface renewal is also useful for dissolving gases into the liquid.
- the presently disclosed gas-liquid surface renewal method can be used to dissolve the prescribed amount of oxygen needed for the growing cells.
- the oxygen composition in the sweeping gas in the headspace is increased, resulting in increased transfer of oxygen to the top surface of the recirculating liquid.
- the oxygen dissolution requirement is low, the oxygen composition in the sweeping gas in the headspace is reduced and replaced with air or nitrogen.
- the variation in oxygen composition of the sweeping gas has little or no impact on the carbon dioxide removal rate.
- the dissolved oxygen concentration is preferably maintained at about 50% in many mammalian cell culture processes.
- very low oxygen concentrations are used in the cell culture solution to enhance protein production by the cells.
- the dissolved carbon dioxide level can be adjusted or maintained at any desirable level. To decrease the dissolved carbon dioxide level at any time during the cell culture process, the flow rate of the sweeping gas going into the headspace of the bioreactor can be increased to more rapidly eliminate CO 2 from the liquid near the surface. The impeller rotational speed can also be increased to speed up the surface liquid renewal rate. To increase the dissolved carbon dioxide level, one would reduce the sweeping gas flow rate and/or decrease rotational speed of the upward pumping impeller.
- additional carbon dioxide is needed as, for example, may be the case in the earliest stages of the process shortly after inoculation of the production bioreactor, it can be added to the sweeping gas mixture in the headspace as required.
- the dissolved oxygen requirement increases as the batch proceeds from the initial lag phase to the end of the exponential growth phase, while the dissolved carbon dioxide concentration increases due to cell respiration, reaches a maximum concentration towards the end of the exponential growth phase, and then is gradually reduced during the production phase. Therefore, gaseous carbon dioxide is added mostly during the lag phase to regulate and maintain pH. Also, some prescribed level of dissolved oxygen needs to be maintained during the cell production phase.
- the gas supply of nitrogen, oxygen and carbon dioxide to the bioreactor vessel is introduced above the top surface of the liquid in the headspace and preferably closely adjacent to the rolling surface of the liquid solution in the bioreactor vessel.
- Such gas introduction can be achieved by making the gas injectors movable so as to always inject the gases at or near the top surface as the liquid level in the bioreactor vessel rises. Impingement of the gas at the rolling top surface reduces the momentum boundary layer on the gas side and improves the total mass transfer rate between the liquid and gas.
- the gas supply may be delivered using fixed gas injectors disposed so as to introduce the gas at a location near the maximum liquid height that will be attained in the bioreactor vessel.
- controlled introduction of the gas supply of nitrogen, air, oxygen and carbon dioxide to the bioreactor vessel may be done by sparging the gases within the solution using one or more spargers disposed within the bioreactor vessel.
- the sparger used to dissolve oxygen can have finer nozzles (or holes) to generate small oxygen bubbles that dissolve or are absorbed before breaking the liquid surface.
- the sparger for the stripping gas typically introduced at considerably higher flow rates, can have much larger nozzles to provide large diameter gas bubbles. Large gas bubbles are less damaging when they break at the surface of the liquid and have less tendency to produce foam.
- Such submerged gas spargers can assist with the independent control of both oxygen and dissolved carbon dioxide levels in combination with the headspace gas exchange method.
- the gas spargers are preferably located apart from the upward flow impeller to maximize their residence time in the cell culture medium. With this method, the stripping gas bubbles are much bigger than those injected into axial flow impellers and the potential for foaming is greatly diminished. Gas exchange now occurs both on the surface and in the bulk of the liquid. Sparging small volumes of gases intermittently for short periods of time allows oxygen uptake and carbon dioxide removal to be maximized without resorting to very high flows of sweeping gas or employing the fastest impeller speeds. It is important that such sparging be done only at peak demand for oxygen dissolution and carbon dioxide removal in order to minimize cell damage.
- the preferred upward pumping device is a helical impeller that can move large volumes of liquid upward with minimal radial flow.
- carbon dioxide removal rate was measured from a simulated broth and reported as Volumetric Mass Coefficient. The higher the mass transfer coefficient, the better the gas exchange efficiency.
- Even with an upward pumping impeller the moving liquid stream is going to be rotated by the rotation of the agitator. As a result, the surface liquid is going to swirl, greatly reducing liquid surface renewal as the surface liquid rotates in the plane of the surface.
- a vertical baffle system is also used on top of the impeller to break the rotation of the liquid and redirect the flow straight to the surface.
- DGC Dynamic Gas Control
- a third sample (identified as Run 40) has a starting level of dissolved carbon dioxide of about 6% to 10% during the lag phase and a high level of variability in dissolved carbon dioxide level ranging from about 5% to about 44% throughout days 4 through 11 of the cell culture process.
- DGC 8 maintained a higher product yield (mg/1) of IgG than the product yield of Run 30 and corresponding product yield of Run 40. Also, the specific productivity (pg/viable cell .day) in DGC 8 with low dCO2 was increased significantly. Specific productivity for the sample processes were about 40 pg/viable cell. day (DGC 8) , 20 pg/viable cell. day (Run 32) and 16 pg/viable cell. day (Run 40), respectively. As evidenced by the DGC 8 data in Figs. 1, 2A, 2B, 2C, and 3, maintaining a stable and low level of dissolved carbon dioxide throughout the cell culture process can enhance cell viability, increase product yield and specific productivity.
- Figs. 4-6 there are shown graphs depicting the characteristics and results of two additional test runs of a mammalian cell culture process.
- the sample runs maintained a generally constant or stable level of dissolved carbon dioxide and moderate osmolality of the cell culture medium.
- Run 50 maintained a moderate level of dissolved carbon dioxide between about 13% and 18% during the exponential growth phase and production phase of the cell culture process
- Run 55 maintained a low level of dissolved carbon dioxide between about 2% and 6% during the exponential growth phase and production phase of the cell culture process.
- Fig. 4 As seen in Fig. 4, Run 50 maintained a moderate level of dissolved carbon dioxide between about 13% and 18% during the exponential growth phase and production phase of the cell culture process whereas Run 55 maintained a low level of dissolved carbon dioxide between about 2% and 6% during the exponential growth phase and production phase of the cell culture process.
- the present system and method preferably maintains a generally constant or stable and low level of dissolved carbon dioxide of less than 10% during the lag and exponential growth phase, and more preferably around 3% to 5% while maintaining a moderate osmolality of between about 300 and 700 mmole/kg, and more preferably between about 350 and 560 mmole/kg during the lag phase and exponential growth phase (See Fig. 1, Fig 4 and Fig. 9).
- This combined dissolved carbon dioxide level and osmolality process condition provides longer cell viability and highest biological product yield during the production phase for given mammalian cell culture processes (see Figs 2, 3, 5, 6, 8, 10 and 11).
- FIG. 7 depicts the dissolved carbon dioxide levels during the growth and production phases of Run 62 which has a low level of dissolved carbon dioxide of about 5% during the lag and exponential growth phases and Run 63 which has a moderate level of dissolved carbon dioxide of about 10% during the lag and exponential growth phases of the cell culture process.
- Fig. 8 further shows that the viable cell density for sample Run 62, with the low level of dissolved carbon dioxide demonstrated a higher degree of cell viability during the production phase than Run 63 having a moderate level of dissolved carbon dioxide.
- Figs. 7 depicts the dissolved carbon dioxide levels during the growth and production phases of Run 62 which has a low level of dissolved carbon dioxide of about 5% during the lag and exponential growth phases and Run 63 which has a moderate level of dissolved carbon dioxide of about 10% during the lag and exponential growth phases of the cell culture process.
- Fig. 8 further shows that the viable cell density for sample Run 62, with the low level of dissolved carbon dioxide demonstrated a higher degree of cell viability during the production phase than
- FIG. 10 and 11 shows that sample Run 62, with the low level of dissolved carbon dioxide demonstrated a higher percentage of cell viability and higher product yield during the production phase that Run 63 having a moderate level of dissolved carbon dioxide.
- the present system and method also provides for higher osmolality and higher levels of dissolved carbon dioxide in the production phase (See Figs. 7 and 9). Such higher osmolalities and higher levels of dissolved carbon dioxide in the production phase may actually enhance the overall bioreactor productivity. Specifically, Fig.
- Fig. 9 shows the osmolalities for Run 62 and Run 63 during the exponential growth phase and production phase of the cell culture process which were maintained in a moderate range of about 350 m ⁇ smol/kg to about 400 m ⁇ smol/kg during the growth phase and between about 400 m ⁇ smol/kg to about 700 m ⁇ smol/kg during the production phase.
- Fig. 7 shows the dissolved carbon dioxide levels during production phase of between about 20% to 50% for Run 62 and between about 20% and 30% for Run 63.
- FIGs. 12 through 17 there are shown charts containing data comparing the cell culture process using Dynamic Gas Control (DGC) compared to a cell culture process without employing the Dynamic Gas Control (DGC).
- DGC Dynamic Gas Control
- the data on the illustrated charts suggest that sample runs employing the Dynamic Gas Control (DGC) process at moderate osmolality, namely samples DGC2 and DGC3,
- the dissolved carbon dioxide was started at about 8.45%, and was subsequently maintained in a range between about 7.0% to 7.5% throughout the remaining cell culture process.
- the dissolved carbon dioxide was started at about 5.5%, and was maintained in a range between about 5.5% to 6.3% for Day 1 and Day 2, and subsequently decreased to about 4.5% at Day 3 and Day 4, and further reduced to about 4.0% from Day 4 to Day 15.
- Run 32 had a dissolved carbon dioxide profile very typical cell culture process where the average dCO2 was maintained about 6% in the growth phase, followed with increasing dCO2 to about 15%, then gradually lowered to about 10% in the production phase.
- Figs 12-17 The data contained in Figs 12-17 shown that the dissolved carbon dioxide levels can be well maintained at desired low level through the process with Dynamic gas Control (DGC) process Both the DGC2 and DGC3 sample runs had higher viable cell density and viability during later stages of protein production. Sample run DGC3 had the highest product titer among these three runs, and reached maximum product titer much earlier than either DGC2 or Run 32.
- Fig. 18 is a table that provides the cell culture process data collected during various sample runs at various combinations of osmolality and dissolved carbon dioxide.
- the present system and method also provides for a low level of dissolved carbon dioxide of less than 10%, and more preferably around 5% or less while diluting the mammalian cell culture batch with water during the in the production phase while adding additional nutrient and cell booster during the production phase.
- This dilution and nutrient supplementation procedure provides higher mammalian cell culture bioreactor product yields and appears to dilute some of the critical toxic waste buildup.
- the present cell culture process optimization and control method comprises: (1) process optimization phase; and (2) active control phase.
- the process optimization phase involves empirically determining the desired pH, osmolality and dissolved carbon dioxide levels for a given mammalian cell culture process, cell line and bioreactor configuration.
- a microprocessor-based controller is then programmed to establish the initial settings as well as permissible values or ranges for overlay gas composition, overlay gas flow rate, sparged gas composition, sparged gas flow rate, acid addition, base addition, nutrient addition, media harvest, etc. to achieve the desired dissolved carbon dioxide and osmolality in the bioreactor while maintaining pH within the desired range and maintaining one or more of the other process parameters such as dissolved oxygen level, agitator speed, temperature, pressure, nutrient content, waste product content, etc. within specifications
- Individual gases or gas mixtures relevant for cell culture bioreactor sparging and overlaying may include the addition and removal of oxygen, nitrogen, air, argon, carbon dioxide, or combinations thereof.
- the empirical determination of desired pH, osmolality and dissolved carbon dioxide level for a given mammalian cell culture process is preferably accomplished in laboratory scale bioreactors running scaled-down process conditions and may be supplemented with appropriate model-based studies.
- the active control phase involves monitoring or measuring a plurality of parameters to be used as inputs to the microprocessor-based controller.
- Such inputs include the dissolved carbon dioxide level, osmolality and pH, as well as optional inputs of dissolved oxygen level, temperature, nutrient and waste product concentration, agitation, gas sparging or overlay gas flow rate and composition, nutrient feed volume and composition and product harvest volume and composition.
- Such inputs are fed to the controller at a regular interval or a continuous basis throughout the production and growth phase of the cell culture process.
- the microprocessor based controller receives the inputs and produces one or more output signals representing the value and setting of at least one parameter selected from the group of overlay gas composition, overlay gas flow rate, sparged gas composition, sparged gas flow rate, agitator speed, acid addition, base addition, nutrient addition, media harvest, etc.
- the output signals are used to control or adjust the overlay gas composition, overlay gas flow rate, sparged gas composition, sparged gas flow rate, agitator speed, acid addition, base addition, nutrient addition, media harvest, etc which maintains the dissolved carbon dioxide level, osmolality, or pH at the desired values or ranges.
- This proposed process control scheme is applicable for nearly constant physiological temperature and also hypothermic cell culture processes. Hypothermic cell culture processes run at least part of the time at less than the typical approx. 37°C process temperature. This proposed process control scheme is also applicable to nearly any configuration of bioreactor and operating in any mode, including batch mode, fed-batch mode, or a continuous mode of operation. [0104] From the foregoing, it should be appreciated that the present invention thus provides various methods and systems for controlling the dissolved carbon dioxide level, pH and osmolality during a mammalian cell culture process to enhance cell viability and biologic product yield. Numerous modifications, changes, and variations of the present methods and systems will be apparent to a person skilled in the art and it is to be understood that such modifications, changes, and variations are to be included within the purview of this application.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8668508P | 2008-08-06 | 2008-08-06 | |
PCT/US2009/052912 WO2010017338A1 (en) | 2008-08-06 | 2009-08-06 | METHOD FOR CONTROLLING pH, OSMOLALITY AND DISSOLVED CARBON DIOXIDE LEVELS IN A MAMMALIAN CELL CULTURE PROCESS TO ENHANCE CELL VIABILITY AND BIOLOGIC PRODUCT YIELD |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2310493A1 true EP2310493A1 (en) | 2011-04-20 |
Family
ID=41130431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09791207A Withdrawn EP2310493A1 (en) | 2008-08-06 | 2009-08-06 | METHOD FOR CONTROLLING pH, OSMOLALITY AND DISSOLVED CARBON DIOXIDE LEVELS IN A MAMMALIAN CELL CULTURE PROCESS TO ENHANCE CELL VIABILITY AND BIOLOGIC PRODUCT YIELD |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2310493A1 (en) |
CN (1) | CN102171331A (en) |
WO (1) | WO2010017338A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8178318B2 (en) * | 2008-08-06 | 2012-05-15 | Praxair Technology, Inc. | Method for controlling pH, osmolality and dissolved carbon dioxide levels in a mammalian cell culture process to enhance cell viability and biologic product yield |
SG181805A1 (en) | 2009-12-18 | 2012-07-30 | Boehringer Ingelheim Int | Method for optimizing a biopharmaceutical production process |
EP2511293A1 (en) | 2011-04-13 | 2012-10-17 | LEK Pharmaceuticals d.d. | A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins |
KR101591671B1 (en) * | 2011-04-29 | 2016-02-04 | 바이오콘 리서치 리미티드 | method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof |
WO2013041487A1 (en) * | 2011-09-21 | 2013-03-28 | F. Hoffmann-La Roche Ag | Co2 profile cultivation |
EP2795982A4 (en) | 2011-12-23 | 2015-12-02 | Nokia Technologies Oy | Shifting harq feedback for cognitive-radio-based td-lte systems |
CN105505852A (en) * | 2012-03-01 | 2016-04-20 | 江苏太平洋美诺克生物药业有限公司 | Method for screening high-tolerance cell line |
WO2014004791A1 (en) * | 2012-06-29 | 2014-01-03 | Stroot Peter | Methods and systems for controlling growth rates of autotrophic microbial cultures |
EP4036208A1 (en) | 2012-10-26 | 2022-08-03 | Massachusetts Institute Of Technology | Humidity control in chemical reactors |
CA3173080A1 (en) | 2013-08-23 | 2015-02-26 | Sanofi | Small volume bioreactors with substantially constant working volumes and associated systems and methods |
US9995758B1 (en) | 2014-10-31 | 2018-06-12 | Western Autotroph Company LLC | Methods and systems for controlling oxidative stress in humans and animals |
CN108051550B (en) * | 2017-12-22 | 2020-07-24 | 吉林冠界生物技术有限公司 | Method for determining main acidic substances in cell culture medium |
CN109517738A (en) * | 2018-12-14 | 2019-03-26 | 杭州奕安济世生物药业有限公司 | A kind of method of carbon dioxide content in regulation bioreactor |
WO2023114949A1 (en) | 2021-12-16 | 2023-06-22 | Sana Biotechnology, Inc. | Methods and systems of particle production |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2530814A (en) * | 1945-10-12 | 1950-11-21 | Schenley Ind Inc | Apparatus for aerating liquids |
US20090280565A1 (en) * | 2005-12-22 | 2009-11-12 | Corporation De L'ecole Polytechique Montr'eal | High-rate perfusion bioreactor |
-
2009
- 2009-08-06 EP EP09791207A patent/EP2310493A1/en not_active Withdrawn
- 2009-08-06 WO PCT/US2009/052912 patent/WO2010017338A1/en active Application Filing
- 2009-08-06 CN CN2009801393185A patent/CN102171331A/en active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO2010017338A1 * |
Also Published As
Publication number | Publication date |
---|---|
CN102171331A (en) | 2011-08-31 |
WO2010017338A1 (en) | 2010-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8178318B2 (en) | Method for controlling pH, osmolality and dissolved carbon dioxide levels in a mammalian cell culture process to enhance cell viability and biologic product yield | |
US20100035342A1 (en) | METHOD FOR CONTROLLING pH, OSMOLALITY AND DISSOLVED CARBON DIOXIDE LEVELS IN A MAMMALIAN CELL CULTURE PROCESS TO ENHANCE CELL VIABILITY AND BIOLOGIC PRODUCT YIELD | |
EP2310493A1 (en) | METHOD FOR CONTROLLING pH, OSMOLALITY AND DISSOLVED CARBON DIOXIDE LEVELS IN A MAMMALIAN CELL CULTURE PROCESS TO ENHANCE CELL VIABILITY AND BIOLOGIC PRODUCT YIELD | |
US9181521B2 (en) | Bioreactor with upward flowing impeller system for use in a mammalian cell culture process | |
US11939559B2 (en) | Method of culturing eukaryotic cells | |
JP7340324B2 (en) | Cell control perfusion in continuous culture | |
Yang et al. | A beginner’s guide to bioprocess modes–batch, fed-batch, and continuous fermentation | |
US20140356852A1 (en) | System and method for micro-aeration based fermentation | |
GB2433266A (en) | Cell culture vessel | |
US20250197793A1 (en) | Culture device and method for controlling culture device | |
EP3165279A1 (en) | Reciprocating stirrer device with microbubble-generating unit | |
US20120295248A1 (en) | Systems and methods for dynamic gas control in a disposable vessel | |
US20120244602A1 (en) | Method for culturing cells or microorganisms | |
CN115927161A (en) | Method for culturing animal cells by using torrent bioreactor | |
JP2014018174A (en) | Cell culture method and cell culture device | |
Kurosawa et al. | High density cultivation of Thiobacillus thiooxidans S3 in a fermentor with cross-flow filtration | |
RU2007120516A (en) | METHOD FOR PRODUCING BEER, PERIODIC METHOD FOR REPRODUCING PURE YEAST CULTURE FOR BREWING AND INSTALLATION FOR ITS IMPLEMENTATION | |
Suphantharika | The influence of dissolved oxygen on the production of difficidin by Bacillus sp. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110125 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: GRINTER, NIGEL Inventor name: HUNEK, BALAZS Inventor name: GUPTA, AMITABH Inventor name: ZHOU, YING Inventor name: CHENG, ALAN, T. Y. |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20131115 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20150106 |